ImmuneHealth
0475.296.139 · rovalta.com · 26/09/2026
NORMAL SITUATION
ImmuneHealth
Company — Normal situation.
Financial year 2021 · Closed on 31/12/2021
Net result18,8 k €-88,4 %over 1 year
Gross margin19,1 k €-88,2 %over 1 year
Equity-2,4 M €+0,8 %over 1 year
Overview
Identity
Source · BCE/KBOImmuneHealth is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0475.296.139
- Legal form
- Non-profit organization
- Latest accounts
- 31/12/2021
Joint committees (1)
- 200
Signals
ProfitableGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 15 filingsTrend over 13 financial years
| 2021 | 2020 | 2019 | 2018 | 2017 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 19,1 k € | -88.2% | 162 k € | -6.0% | 172,3 k € | -36.1% | 269,7 k € | +561% | -58,5 k € |
| EBITDA | 19,1 k € | -88.2% | 161,8 k € | -5.9% | 172 k € | -36.2% | 269,7 k € | +532% | -62,4 k € |
| Operating result | 19,1 k € | -88.2% | 161,8 k € | -5.9% | 172 k € | -36.0% | 268,7 k € | +529% | -62,6 k € |
| Net result | 18,8 k € | -88.4% | 161,8 k € | -5.7% | 171,7 k € | -36.1% | 268,5 k € | +501% | -67 k € |
| Balance sheet | |||||||||
| Equity | -2,4 M € | +0.8% | -2,5 M € | +6.2% | -2,6 M € | +6.2% | -2,8 M € | +8.8% | -3,1 M € |
| Total assets | 193,9 k € | +11.4% | 174,1 k € | +458% | 31,2 k € | -9.9% | 34,6 k € | +592% | 5 k € |
| Cash | 170,1 k € | +0.4% | 169,5 k € | +453% | 30,7 k € | -9.4% | 33,9 k € | +1084% | 2,9 k € |
| Debts | 2,6 M € | +0.0% | 2,6 M € | -0.7% | 2,6 M € | -6.3% | 2,8 M € | -7.9% | 3 M € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Board of directors
Source · NBB, accounts to 31/12/20212 active · 65 ended
Active mandates
Daniele CARATI
ActiveDidier GEORGES
ActiveEnded mandates
Daniele CARATI
EndedDaniele CARATI
EndedDidier GEORGES
EndedDominique DEMONTE
EndedFinancials
Full financial information
Source · NBB| 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 | 01/01/2017 | 01/01/2015 |
| Closing of the financial year | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 | 31/12/2017 | 31/12/2015 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 24/08/2022 | 01/06/2021 | 10/09/2020 | 30/08/2019 | 14/09/2018 | 08/07/2016 |
| General meeting | 19/08/2022 | 27/04/2021 | 30/06/2020 | 25/06/2019 | 26/06/2018 | 28/06/2016 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 15 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2021 | 19/08/2022 | 24/08/2022 | French | |
| Abridged model | 31/12/2020 | 27/04/2021 | 01/06/2021 | French | |
| Abridged model | 31/12/2019 | 30/06/2020 | 10/09/2020 | French | |
| Abridged model | 31/12/2018 | 25/06/2019 | 30/08/2019 | French | |
| Abridged model | 31/12/2017 | 26/06/2018 | 14/09/2018 | French | |
| Abridged model | 31/12/2015 | 28/06/2016 | 08/07/2016 | French | |
| Abridged model | 31/12/2014 | 08/05/2015 | 17/03/2016 | French | |
| Abridged model | 31/12/2013 | 24/04/2014 | 25/08/2014 | French | |
| Abridged model | 31/12/2012 | 16/04/2013 | 05/11/2013 | French | |
| Abridged model | 31/12/2011 | 25/04/2012 | 23/05/2013 | French | |
| Abridged model | 31/12/2010 | 28/04/2011 | 23/05/2013 | French | |
| Abridged model | 31/12/2009 | 29/04/2010 | 30/11/2010 | French | |
| Abridged model | 31/12/2008 | 30/04/2009 | 06/01/2010 | French | |
| Abridged model | 31/12/2007 | 23/04/2008 | 29/01/2010 | French | |
| Abridged model | 31/12/2006 | 17/04/2007 | 28/09/2007 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20212 active · 65 ended
Active mandates
Daniele CARATI
ActiveDidier GEORGES
ActiveEnded mandates
Daniele CARATI
EndedDaniele CARATI
EndedDidier GEORGES
EndedDominique DEMONTE
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution19/01/2023RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
- Mandates22/10/2019DEMISSIONS, NOMINATIONS
- Mandates31/07/2014DEMISSIONS, NOMINATIONS
- Mandates09/10/2013DEMISSIONS, NOMINATIONS
- Mandates28/06/2012DEMISSIONS, NOMINATIONS
- Mandates10/04/2012DEMISSIONS, NOMINATIONS
- Mandates04/11/2011DEMISSIONS, NOMINATIONS
- Mandates06/05/2009DENOMINATION - DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2021Annual accounts 202118,8 k €↓
- 2020Annual accounts 2020161,8 k €↓
- 2019Annual accounts 2019171,7 k €↓
- 2018Annual accounts 2018268,5 k €↑
- 2017Annual accounts 2017-67 k €↑
- 2015Annual accounts 2015-438,9 k €↓
- 2014Annual accounts 2014-174,4 k €↓
- 2013Annual accounts 201334,6 k €↑
- 2012Annual accounts 2012-1,2 M €↓
- 2011Annual accounts 2011-32,5 k €↑
- 2010Annual accounts 2010-464,7 k €↓
- 2009Annual accounts 2009-132,3 k €↓
- 2008Annual accounts 200816,1 k €